BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 866374)

  • 1. In vitro effect of suloctidil on 14C-5-hydroxytryptamine uptake and liberation in rat platelets.
    de Gaetano G; Roncaglioni MC; Miragliotta G; Wielosz M; Garattini S
    Pharmacol Res Commun; 1977 Apr; 9(4):315-24. PubMed ID: 866374
    [No Abstract]   [Full Text] [Related]  

  • 2. Interference by fenfluramine with the storage of 14C-5-hydroxytryptamine in rat platelets.
    Wielosz M; Roncaglioni MC; de Gaetano G; Garattini S
    Arch Int Pharmacodyn Ther; 1977 Feb; 225(2):232-9. PubMed ID: 849072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of fenfluramine on 5-hydroxytryptamine uptake and release by rat blood platelets.
    Buczko W; De Gaetano G; Garattini S
    Br J Pharmacol; 1975 Apr; 53(4):563-8. PubMed ID: 1148499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake of 14C-5-hydroxytryptamine by human and rat platelets and its pharmacological inhibition. A comparative kinetic analysis.
    Wielosz M; Salmona M; de Gaetano G; Garattini S
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Dec; 296(1):59-65. PubMed ID: 1012348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the inhibition of 5-hydroxytryptamine uptake by methadone and its congeners in human platelets.
    Brase DA; Loh HH
    Biochem Pharmacol; 1976 Jul; 25(14):1684-6. PubMed ID: 942469
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of 4-methyl-alpha-ethyl-tyramine, 4, alpha-dimethyl-tyramine and tetrabenazine on the release and uptake of 5-hydroxytryptamine by human blood platelets in vitro.
    Campbell IC; Todrick
    Life Sci; 1976 May; 18(10):1091-7. PubMed ID: 933699
    [No Abstract]   [Full Text] [Related]  

  • 7. Fenfluramine and 5-hydroxytryptamine. Part 2: Involvement of brain 5-hydroxytryptamine in the anorectic activity of fenfluramine.
    Duhault J; Boulanger M; Voisin C; Malen C; Schmitt H
    Arzneimittelforschung; 1975 Nov; 25(11):1758-62. PubMed ID: 128366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcellular distribution of [14C]5-hydroxytryptamine in the blood platelets of rabbits: effects of imipramine and and haloperidol.
    Hussein L; Goedde HW; Rosenfeld M; Freerksen E
    Hoppe Seylers Z Physiol Chem; 1978 Jul; 359(7):803-11. PubMed ID: 680641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Backward walking and circling: behavioural responses induced by drug treatments which cause simultaneous release of catecholamines and 5-hydroxytryptamine.
    Curzon G; Fernando JC; Lees AJ
    Br J Pharmacol; 1979 Aug; 66(4):573-9. PubMed ID: 465894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of monoamine uptake inhibitors on extracellular and platelet 5-hydroxytryptamine in rat blood: different effects of clomipramine and fluoxetine.
    Ortiz J; Artigas F
    Br J Pharmacol; 1992 Apr; 105(4):941-6. PubMed ID: 1387022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphetamine derivatives interact with both plasma membrane and secretory vesicle biogenic amine transporters.
    Schuldiner S; Steiner-Mordoch S; Yelin R; Wall SC; Rudnick G
    Mol Pharmacol; 1993 Dec; 44(6):1227-31. PubMed ID: 7903417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of mazindol, fenfluramine and chlorimipramine on the 5-hydroxytryptamine uptake and storage mechanisms in rat brain: similarities and differences.
    Carruba MO; Picotti GB; Zambotti F; Mantegazza P
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Nov; 300(3):227-32. PubMed ID: 600310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioural responses to drugs releasing 5-hydroxytryptamine and catecholamines: effects of treatments altering precursor concentrations in brain.
    Fernando JC; Curzon G
    Neuropharmacology; 1981 Feb; 20(2):115-22. PubMed ID: 7207710
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of mazindol and d-fenfluramine of 5-hydroxytryptamine uptake, storage and metabolism in blood platelets.
    Picotti GB; Carruba MO; Zambotti F; Mantegazza P
    Eur J Pharmacol; 1977 Apr; 42(3):217-24. PubMed ID: 856607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered uptake and release of 14C-serotonin in platelets following incubation of platelet-rich plasma with EDTA.
    Grant RA; Zucker MB
    Thromb Res; 1979; 14(6):981-6. PubMed ID: 112710
    [No Abstract]   [Full Text] [Related]  

  • 16. From clomipramine to mianserin: therapeutic relevance of interactions with serotonin uptake and storage, as studied in the blood platelet model.
    Lingjaerde O
    Acta Psychiatr Scand Suppl; 1985; 320():10-9. PubMed ID: 3901671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of d-fenfluramine and p-chloroamphetamine on H75/12-induced depletion of 5-hydroxytryptamine and dopamine in the rat brain.
    Fattaccini CM; Gozlan H; Hamon M
    Neuropharmacology; 1991 Jan; 30(1):15-23. PubMed ID: 1710793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous effects of p-chloroamphetamine, d-fenfluramine, and reserpine on free and stored 5-hydroxytryptamine in brain and blood.
    Martín F; Artigas F
    J Neurochem; 1992 Sep; 59(3):1138-44. PubMed ID: 1379630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo effect of danitracen on the uptake mechanisms in monoaminergic neurons and platelets in rats.
    Wielosz M; Przegaliński E; Kieinrok Z
    Pol J Pharmacol Pharm; 1978; 30(2-3):263-8. PubMed ID: 673930
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of suloctidil [1(4-isopropylthiophenyl)-2-n-octylaminopropanol] on human platelets in vitro.
    Mürer EH; Niewiarowski S; Stewart GJ
    Biochem Pharmacol; 1979; 28(4):471-8. PubMed ID: 426866
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.